[go: up one dir, main page]

DE60112601D1 - Behandlung von tinnitus - Google Patents

Behandlung von tinnitus

Info

Publication number
DE60112601D1
DE60112601D1 DE60112601T DE60112601T DE60112601D1 DE 60112601 D1 DE60112601 D1 DE 60112601D1 DE 60112601 T DE60112601 T DE 60112601T DE 60112601 T DE60112601 T DE 60112601T DE 60112601 D1 DE60112601 D1 DE 60112601D1
Authority
DE
Germany
Prior art keywords
tinnitus
treatment
inner ear
acetylcholine receptor
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60112601T
Other languages
English (en)
Other versions
DE60112601T2 (de
Inventor
Peter Ruppersberg
Bernd Fakler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TINNITUS FORSCHUNGS und ENTWIC
Original Assignee
TINNITUS FORSCHUNGS und ENTWIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TINNITUS FORSCHUNGS und ENTWIC filed Critical TINNITUS FORSCHUNGS und ENTWIC
Publication of DE60112601D1 publication Critical patent/DE60112601D1/de
Application granted granted Critical
Publication of DE60112601T2 publication Critical patent/DE60112601T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DE60112601T 2000-09-21 2001-09-21 Behandlung von tinnitus Expired - Fee Related DE60112601T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00120652A EP1190709A1 (de) 2000-09-21 2000-09-21 Behandlung von Tinnitus
EP00120652 2000-09-21
PCT/EP2001/010932 WO2002024176A2 (en) 2000-09-21 2001-09-21 Treatment of tinnitus

Publications (2)

Publication Number Publication Date
DE60112601D1 true DE60112601D1 (de) 2005-09-15
DE60112601T2 DE60112601T2 (de) 2006-06-08

Family

ID=8169903

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60112601T Expired - Fee Related DE60112601T2 (de) 2000-09-21 2001-09-21 Behandlung von tinnitus

Country Status (7)

Country Link
US (2) US20040038884A1 (de)
EP (3) EP1190709A1 (de)
AT (1) ATE301458T1 (de)
AU (1) AU2002210512A1 (de)
CA (1) CA2422527A1 (de)
DE (1) DE60112601T2 (de)
WO (1) WO2002024176A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399018B2 (en) * 2008-07-21 2013-03-19 Otonomy, Inc. Controlled release ion channel modulator compositions and methods for the treatment of otic disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683912A (en) * 1994-07-21 1997-11-04 The Salk Institute For Biological Studies Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit
DE19528388A1 (de) * 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
GB9618341D0 (en) * 1996-09-03 1996-10-16 Scotia Holdings Plc Method of treatment
AU5170400A (en) * 1999-05-27 2000-12-18 George F. El Khoury Topical application of muscarinic and opioid agents for treatment of tinnitus
EP1090991A1 (de) * 1999-09-29 2001-04-11 Sanofi-Synthelabo Nikotin-acetylcholin-Rezeptor, dessen Isolierung und Verwendung

Also Published As

Publication number Publication date
EP1331931A2 (de) 2003-08-06
AU2002210512A1 (en) 2002-04-02
EP1190709A1 (de) 2002-03-27
WO2002024176A2 (en) 2002-03-28
EP1559420A1 (de) 2005-08-03
US20090093613A1 (en) 2009-04-09
US20040038884A1 (en) 2004-02-26
DE60112601T2 (de) 2006-06-08
WO2002024176A3 (en) 2003-05-22
EP1331931B1 (de) 2005-08-10
ATE301458T1 (de) 2005-08-15
CA2422527A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
ATE504557T1 (de) Aspirin-ausgelöste lipidmediatoren
DE60131138D1 (de) Antibakterielle mittel
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
NO20034056D0 (no) Proliferative sykdommer
WO2003099110A3 (en) Herbs and herbal combinations useful for the treatment of microbial infections
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
CL2004000551A1 (es) Compuestos derivados de triazol sustituidos con biarilo, sus sales, bloqueadores del canal de sodio; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento o prevencion del dolor.
TR200200821T2 (tr) 5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı.
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
EE200200547A (et) Neovaskularisatsiooni parendatud ravi
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
DK1763339T3 (da) Orale antimikrobielle farmaceutiske præparater
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
DE60112601D1 (de) Behandlung von tinnitus
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee